| Successful rapid rituximab desensitization for hypersensitivity reactions to monoclonal antibodies in a patient with rheumatoid arthritis: a remarkable option. O Abadoglu, K Epozturk, E Atayik, E Kaptanoglu Journal of Investigational Allergology & Clinical Immunology 21 (4), 319-321, 2011 | 16 | 2011 |
| Rapid oral desensitisation to prophylactic isoniazid O Abadoglu, K Epozturk, E Atayik Allergologia et Immunopathologia 39 (5), 311-312, 2011 | 10 | 2011 |
| A single center experience of super-responders among severe asthma patients receiving treatment with mepolizumab E Atayık, G Aytekin Turkish Thoracic Journal 23 (5), 348, 2022 | 6 | 2022 |
| The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment E Atayik, G Aytekin Revue Française d'Allergologie 62 (8), 684-688, 2022 | 5 | 2022 |
| SARS-CoV-2 in a patient with persistent asthma taking omalizumab: the first case in Turkey E Atayık, G Aytekin Asthma Allergy Immunology 18, 23-26, 2020 | 4 | 2020 |
| Mepolizumab-related adverse events in severe eosinophilic asthma: A real-life study SN Bahçecioğlu, M Türk, E Atayık, GP Çetin, B Arslan, İ Gülmez Asthma Allergy Immunol 2022; 20: 81 6, 2022 | 2 | 2022 |
| Tocilizumab‑induced anaphylaxis in two patients with COVID‐19‐induced cytokine storm GA Emel ATAYIK Journal of Emergency Medicine Case Reports 12 (1), 7-11, 2021 | 2* | 2021 |
| Kronik Obstrüktif Akciğer Hastalığı Alevlenmelerinde Pulmoner Tromboemboli Oranı S CANBAKAN, E AKINCI, N ÇAPAN, M GÜLHAN, A ERTÜRK, Y DADALI Solunum Hastalıkları 17, 155-160, 2006 | 2 | 2006 |
| The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma E Atayik, G Aytekin, I Aydin, E Omeroglu Iranian Journal of Allergy, Asthma and Immunology, 2024 | 1 | 2024 |
| The efficacy of omalizumab treatment in patients with non-atopic severe asthma E Atayik, G Aytekіn medRxiv, 2022.01. 29.22270075, 2022 | 1 | 2022 |
| The course of COVID-19 in allergic rhinitis patients receiving allergen spesific immunotherapy E Atayik, G Aytekіn medRxiv, 2022.01. 29.22270072, 2022 | 1 | 2022 |
| Are allergic diseases a risk factor for systemic side effects after COVID-19 vaccines? E Atayik, G Aytekіn medRxiv, 2022.01. 23.22269704, 2022 | 1 | 2022 |
| First SARS-CoV-2 Infection in Patients with Severe Asthma Receiving Mepolizumab. E Atayık, G Aytekin Respiratory Case Reports 10 (2), 2021 | 1 | 2021 |
| Rapid rituximab desensitisation in a patient with rheumatoid arthritis O Abadoglu, K Epozturk, E Atayik, E Kaptanoglu Allergy 66, 607-608, 2011 | 1 | 2011 |
| Second line chemotherapy with docetaxel in advanced non small lung cancer: retrospective analysis of 33 cases M Gülhan, A Ertürk, S Canbakan, E Ünsal, E Akıncı, N Çapan | 1 | 2007 |
| Are Allergic Diseases a Risk Factor for Systemic Side Effects After COVID-19 Vaccines? COVID-19 and Vaccines E Atayık, G Aytekin, H Özer Journal of European Internal Medicine Professionals 2 (1), 2024 | | 2024 |
| Samter Syndrome EA Atayık, C Cingi, H Negm Airway diseases, 1-11, 2023 | | 2023 |
| POSTER: CLL-148 Case Report: Combined Chronic Lymphocytic Leukemia and Primary Immune Failure S Yılmaz, E Musluk, E Atayık Clinical Lymphoma Myeloma and Leukemia 23, S174, 2023 | | 2023 |
| CLL-148 Case Report: Combined Chronic Lymphocytic Leukemia and Primary Immune Failure S Yılmaz, E Musluk, E Atayık Clinical Lymphoma Myeloma and Leukemia 23, S322, 2023 | | 2023 |
| Allergologia et Immunopathologia: The only way to move ahead is to grow LG Marcos Allergologia et Immunopathologia 51 (1), 195-196, 2023 | | 2023 |
